Navigation Links
Genomes show how Staph bacteria gain resistance to last-line drug
Date:5/22/2012

National Institutes of Health-funded scientists have determined the genome sequences of a dozen strains of Staphylococcus aureus bacteria known to be resistant to vancomycin, an antibiotic of last resort. The researchers demonstrated -that resistance arose independently in each strain, and identified shared features among the strains that may have helped them acquire vancomycin resistance and evade human immune defenses.

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of hospital-acquired infections in the United States, causing an estimated 18,000 deaths in 2005, the most recent data available. Severe multidrug-resistant MRSA infections require treatment with last-line antibiotics such as vancomycin. Since 2002, 12 cases of vancomycin-resistant S. aureus (VRSA) have been documented in the United States, raising concern that staph infections might become untreatable if vancomycin resistance became widespread. Most of the VRSA cases arose in people with diabetes who had limb infections characterized by the presence of multiple kinds of bacteria, including vancomycin-resistant Enterococcus bacteria.

By comparing the genetic differences among 12 VRSA strains available for study, the researchers found that the strains last shared a common ancestor more than 50 years ago, well before the emergence of vancomycin resistance. The gene sequences showed that rather than spreading from person to person, vancomycin resistance appeared anew in each VRSA case. The team found that each VRSA strain acquired a bit of genetic material called transposon Tn1546, which likely came from vancomycin-resistant Enterococcus bacteria that simultaneously infected the patients.

All the VRSA strains belong to the CC5 family, or clade, of Staphylococcus. The CC5 clade is usually found in antibiotic-resistant hospital-acquired staph infections. The genome data showed that CC5 clade strains lack the ability to make a natural antibacterial colonizing factor, which is why they can co-exist with Enterococcus. The study also revealed that CC5 strains make proteins that disrupt a variety of human immune responses and allow the bacteria to flourish, increasing the odds that resistance factors will be transferred from Enterococcus to Staphylococcus bacteria in a mixed infection.

The genomes provided clues as to why person-to-person spread of VRSA has not become common. Without the ability to make or resist the antibacterial colonizing factor, CC5 clade members are at a disadvantage in any encounter with other naturally occurring staph strains that normally live on the skin and that do produce this factor.


'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Researchers Look at Genomes of Nonsmokers With Lung Cancer
2. Scientists Create First Monkeys With Mixed Genomes
3. International team to sequence genomes of fungi
4. Einstein researcher helps lead consortium for $10 million X Prize to sequence genomes of 100 centenarians
5. Orangutan Genomes Reveal Some Surprises
6. Punctuated evolution in cancer genomes
7. NIH-supported scientists investigate a newly emerging staph strain
8. Study Offers Update on Staph Pneumonia Trends in Children
9. Study finds livestock-related Staph strain in child care worker
10. Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide
11. Discovery of 2 new genes provides hope for stemming Staph infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2019)... ... 2019 , ... While the holidays are a time for joy and sharing, ... AgriLife Extension Service specialists. , “There are many behavioral and logistical ... wellness,” said Joyce Cavanagh, AgriLife Extension specialist in family economics, College Station. , Prioritize ...
(Date:12/4/2019)... ... 04, 2019 , ... Eolas Therapeutics Inc. today announced the ... dependence. The study will investigate safety and pharmacokinetics (PK) of AZD4041 in healthy ... receptors that is being developed in collaboration with AstraZeneca. , “Smoking-related diseases are ...
(Date:12/2/2019)... ... December 02, 2019 , ... TrialScope, the ... EMD Serono, the North American branch of the healthcare business of Merck KGaA, ... designed to educate and inform patients, caregivers, the public, patient advocacy groups and ...
(Date:12/2/2019)... ... December 02, 2019 , ... The Sterling ... the Sterile Processing Department. The elegant design provides a smooth polycarbonate surface that ... sliding doors that allow for manual loading that provides high flexibility and uses ...
(Date:11/30/2019)... , ... November 28, 2019 , ... ... known for its award-winning cannabis cultivation, production and dispensary operations, has received a ... line of products. , “This is a great accomplishment for our company and ...
Breaking Medicine News(10 mins):
(Date:11/27/2019)... ANGELES (PRWEB) , ... November 27, 2019 , ... A ... makeup trends. These particular trends focus on looking festive in a creative way for ... of eyeliner to a more challenging application of tiny rhinestones around the eyes to ...
(Date:11/23/2019)... ... 22, 2019 , ... For the third year in a row, Shaw Industries ... conference and expo in addition to showcasing a test installation of an innovative new ... Contract and Shaw Floors Builder Group brands. , Shaw offered five CEU-credit approved education ...
(Date:11/22/2019)... ... November 22, 2019 , ... Respected dentists in ... of the Implant Dentistry Continuum™. This comprehensive continuing education course provides in-depth lectures ... The dentists at Nash Family Dentistry offer full-service dental implant treatment, both placing ...
Breaking Medicine Technology: